TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY
Publication
, Conference
Jacobson, IM; McHutchison, JG; Dusheiko, GM; Di Bisceglie, AM; Reddy, R; Bzowej, NH; Marcellin, P; Muir, AJ; Bengtsson, L; Dunne, AM; Adda, N ...
Published in: HEPATOLOGY
October 1, 2010
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2010
Volume
52
Issue
4
Start / End Page
427A / 427A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Jacobson, I. M., McHutchison, J. G., Dusheiko, G. M., Di Bisceglie, A. M., Reddy, R., Bzowej, N. H., … Zeuzem, S. (2010). TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY. In HEPATOLOGY (Vol. 52, pp. 427A-427A). Boston, MA: WILEY-BLACKWELL.
Jacobson, Ira M., John G. McHutchison, Geoffrey M. Dusheiko, Adrian M. Di Bisceglie, Rajender Reddy, Natalie H. Bzowej, Patrick Marcellin, et al. “TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY.” In HEPATOLOGY, 52:427A-427A. WILEY-BLACKWELL, 2010.
Jacobson IM, McHutchison JG, Dusheiko GM, Di Bisceglie AM, Reddy R, Bzowej NH, et al. TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY. In: HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 427A-427A.
Jacobson, Ira M., et al. “TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY.” HEPATOLOGY, vol. 52, no. 4, WILEY-BLACKWELL, 2010, pp. 427A-427A.
Jacobson IM, McHutchison JG, Dusheiko GM, Di Bisceglie AM, Reddy R, Bzowej NH, Marcellin P, Muir AJ, Bengtsson L, Dunne AM, Adda N, George S, Kauffman RS, Zeuzem S. TELAPREVIR IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN GENOTYPE 1 HCV TREATMENT-NAIVE PATIENTS: FINAL RESULTS OF PHASE 3 ADVANCE STUDY. HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 427A-427A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2010
Volume
52
Issue
4
Start / End Page
427A / 427A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics